Inactive Instrument
Phosphagenics Limited Stock Australian S.E.
Stocks
AU000000POH7
Pharmaceuticals
OTC Markets Traded| Market Cap | 76.61M 53.06M 46.62M 43.52M 39.94M 74.77M 5.08B 516M 202M 2.51B 199M 195M 8.69B | P/E 2024 |
-2.5x | P/E 2025 | -6.43x |
|---|---|---|---|---|---|
| Enterprise Value | 71.96M 49.84M 43.79M 40.88M 37.52M 70.23M 4.77B 485M 190M 2.36B 187M 183M 8.17B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 23x |
| Free-Float |
76.76% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -14.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul David Gavin
CEO | Chief Executive Officer | - | 01/05/2020 |
Roksan Libinaki
COO | Chief Operating Officer | - | 01/05/2020 |
Naomi Lawrie
SEC | Corporate Secretary | - | 01/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Murdoch
BRD | Director/Board Member | - | 13/04/2015 |
Gregory Collier
CHM | Chairman | - | 01/01/2019 |
Kathy Connell
BRD | Director/Board Member | 59 | 26/04/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -14.29% | -14.29% | - | - | 56.13M | ||
| -0.87% | +4.04% | +58.60% | +163.92% | 1,089B | ||
| -0.45% | +3.87% | +57.95% | +52.18% | 643B | ||
| +0.04% | +3.95% | +37.69% | +74.54% | 465B | ||
| -1.69% | +8.81% | +39.38% | +34.26% | 359B | ||
| -0.51% | +3.51% | +36.97% | +43.76% | 303B | ||
| +1.50% | +3.40% | +17.71% | +18.77% | 267B | ||
| +0.79% | +5.81% | -2.55% | -36.02% | 226B | ||
| -1.39% | +5.90% | +27.70% | +64.00% | 212B | ||
| -1.18% | +1.83% | +16.20% | +72.69% | 167B | ||
| Average | -1.80% | +4.77% | +32.18% | +54.23% | 414.57B | |
| Weighted average by Cap. | -0.51% | +4.90% | +41.99% | +79.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.13M 785K 689K 643K 591K 1.11M 75.14M 7.63M 2.98M 37.18M 2.95M 2.88M 129M | 1.24M 857K 753K 703K 645K 1.21M 82.11M 8.34M 3.26M 40.63M 3.22M 3.15M 140M |
| Net income | -3.12M -2.16M -1.9M -1.77M -1.63M -3.05M -207M -21.03M -8.22M -102M -8.12M -7.94M -354M | -4.42M -3.06M -2.69M -2.51M -2.3M -4.31M -293M -29.75M -11.64M -145M -11.49M -11.24M -501M |
| Net Debt | -1.3M -899K -790K -737K -677K -1.27M -86.1M -8.74M -3.42M -42.61M -3.38M -3.3M -147M | -4.65M -3.22M -2.83M -2.64M -2.42M -4.54M -308M -31.32M -12.25M -153M -12.09M -11.83M -528M |
Employees
-
Sector
Pharmaceuticals
















